Zhang Luankun

Laboratory of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, PR China.

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers43 papers

Sort

By YearBy Citation

Combined model of frameshift mutations and TMB in predicting response to immunotherapy in NSCLC

H. Zhou,J. Liu,Y. Zhang,W. Fang,L. Zhang

ANNALS OF ONCOLOGY, no. SUPnan (2019)

Bibtex

Mendelian randomization study of Alzheimer's disease and lung cancer

H. Zhou,J. Shen,Y. Zhang,J. Liu,Y. Huang,L. Zhang

ANNALS OF ONCOLOGY, no. SUPnan (2019)

Bibtex

LBA3 Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (aNSCLC): CheckMate 227 - part 2 final analysis

L. Paz-Ares,T.E. Ciuleanu, X. Yu,P. Salman, A. Pluzanski, A. Nagrial,L. Havel,R. Kowalyszyn,C. Audigier-Valette,Y.-L. Wu,H. Borghaei,M.D. Hellmann

Annals of Oncology, (2019)

Bibtex

319OCombined model of frameshift mutations and TMB in predicting response to immunotherapy in NSCLC

H Zhou,J Liu,Y Zhang, W Fang,L Zhang

(2019)

Bibtex

P1.11-09 Risk of Second Primary Malignancy After Non-Small-Cell Lung Cancer: A Competing Risk Nomogram Based on the SEER Database

H. Zhou,J. Shen,Y. Zhang,Y. Huang,W. Fang,Y. Yang,S. Hong,G. Chen,S. Zhao,X. Chen, Z. Zhang, J. Liu

Journal of Thoracic Oncology, no. 10 (2019)

Bibtex

P2.04-13 Interleukin-18 and Lung Cancer: A Mendelian Randomization Study

J. Liu, H. Zhou,Y. Zhang,W. Fang,Y. Yang,S. Hong, G. Chen,S. Zhao, Z. Zhang,J. Shen,W. Xian, Y. Huang

Journal of Thoracic Oncology, no. 10 (2019)

Bibtex

A Mendelian randomization study of the effects of Crohn's disease on lung cancer

J. Liu,H. Zhou,Y. Zhang,W. Fang,Y. Yang,S. Hong,G. Chen,S. Zhao,J. Shen,W. Xian,Y. Huang,H. Zhao

ANNALS OF ONCOLOGY, no. SUPnan (2019)

Bibtex

49PA Mendelian randomization study of the effects of Crohn’s disease on lung cancer

J Liu, H Zhou, Y Zhang,W Fang,Y Yang,S Hong,G Chen,S Zhao,J Shen, W Xian,Y Huang,H Zhao

Annals of Oncology, (2019): ii18

WOSBibtex

60PNomogram for patients with stage I small cell lung cancer: A competing risk analysis

J Liu, H Zhou, Y Zhang,W Fang,Y Yang,S Hong,G Chen,S Zhao,X Chen, Z Zhang, W Xian,J Shen

Annals of Oncology, (2019): ii22

WOSBibtex

48PEducation and lung cancer: A Mendelian randomisation study

H Zhou,Y Zhang,J Liu,Y Yang,W Fang,S Hong,G Chen,S Zhao, Z Zhang,J Shen, W Xian,Y Huang

Annals of Oncology, (2019): ii18

WOSBibtex

PBRM1 mutation and preliminary response to immune checkpoint blockade treatment in NSCLC

J. Liu,H. Zhou,Y. Zhang,Y. Huang,Y. Yang,W. Fang,L. Zhang

ANNALS OF ONCOLOGY, no. SUPnan (2019)

Bibtex

Blood trace minerals and lung cancer: A Mendelian randomization study

W. Xian,H. Zhou,Y. Zhang,J. Shen,J. Liu,L. Zhang

ANNALS OF ONCOLOGY, no. SUPnan (2019)

Bibtex

OA10 CheckMate 078: Patient-Reported Outcomes (PROs) With Nivolumab vs Docetaxel in Advanced Non-Small Cell Lung Cancer (NSCLC)

Y. Wu,J. Chang,L. Zhang,H. Tu,L. Wu,J. Feng,S. Lu,C. Zhou,J. Wang,T. Mok,F. Taylor, B. Mossman

Journal of Thoracic Oncology, no. 12 (2018): S1047-S1048

Bibtex

383PWhether pericarcinomatous tissue of non-small cell lung cancer can serve as genetic background filter in next-generation sequencing analysis

Y Zhang,L Zhang, L Chang,Y Yang,W Fang,Y Guan,X Xia,X Yi

Annals of Oncology, (2018)

WOSBibtex

428PEfficacy of single dose NEPA, a fixed combination of netupitant and palonosetron, versus a 3-day regimen of aprepitant/granisetron (APR/GRAN) for prevention of nausea in patients receiving high dose cisplatin

A Dechaphunkul,S Lu, S Olivari,L Zhang

ANNALS OF ONCOLOGY, no. SUPnan (2018)

WOSBibtex

P101 Intratumor Heterogeneity Comparison Among Different Subtypes of NSCLC Through Multi-region Tissue And ctDNA Sequencing

Y. Zhang,Y. Yang,W. Fang,L. Chang,L. Zhang

Journal of Thoracic Oncology, no. 12 (2018)

Bibtex

P1.01-110 Three Specific HER2 Mutations Predict Favorable Outcomes in Advanced Lung Cancer Patients Treated with Afatinib

S. Zhao,Wentao Fang,Yang Y,L. Zhang

Journal of Thoracic Oncology, no. 10 (2018)

Bibtex

P038 Docosapentaenoic Acid and Lung Cancer Risk: A Mendelian Randomisation Study

J. Liu,H. Zhou,Y. Zhang,Y. Huang,W. Fang,Y. Yang,S. Hong,G. Chen,S. Zhao,X. Chen,Z. Zhang,J. Shen

Journal of Thoracic Oncology, no. 12 (2018): S1065

Bibtex

P088 Distribution of Different HER2 Mutations and Their Impact on Clinical Responses to Afatinib in HER2-Mutant Lung Cancer

W. Fang,S. Zhao,Y. Liang, Y. Yang,L. Yang,X. Dong,L. Zhang,Y. Tang, S. Wang,X. Ma,M. Wang,W. Wang

Journal of Thoracic Oncology, no. 12 (2018): S1080

Bibtex

P102 The Correlations of Tumor Mutational Burden Among Single-region Tissue, Multi-region Tissues And Blood in NSCLC

Y. Zhang,W. Fang,Y. Yang,L. Chang,L. Zhang

Journal of Thoracic Oncology, no. 12 (2018)

Bibtex

View All

Base Info Papers Patents Projects